Experience

SUN bioscience

• Switzerland
• Biotechnology Research
• 1 - 100 Employee

• Founder, CEO and Board Member

  • Jan 2016 - Present

  Lausanne und Umgebung, Schweiz SUN bioscience was founded at EPFL (Swiss Federal Institute of Technology in Lausanne, Switzerland) and commercializes Gri3D, the global leading technology for organoid cultures, a unique and scalable 3D-cell culture platform that simplifies organoid workflows. Gri3D is a plug and play solution that utilizes SUN bioscience’s distinctive PEG-based hydrogel microwell arrays and provides pharmaceutical companies and researchers with a scalable, precise, and efficient solution for growing organoid… Show more SUN bioscience was founded at EPFL (Swiss Federal Institute of Technology in Lausanne, Switzerland) and commercializes Gri3D, the global leading technology for organoid cultures, a unique and scalable 3D-cell culture platform that simplifies organoid workflows. Gri3D is a plug and play solution that utilizes SUN bioscience’s distinctive PEG-based hydrogel microwell arrays and provides pharmaceutical companies and researchers with a scalable, precise, and efficient solution for growing organoid models. Show less



Doppl SA

• Switzerland
• Biotechnology Research
• 1 - 100 Employee

• Founder and Board Member

  • Mar 2022 - Present

  Lausanne, Vaud, Switzerland DOPPL is implementing the worldwide first organoid automation and screening platform, that is validated to support clinical diagnostic services. The Company performs milestone-based co-development projects with pharmaceutical R&D to de-risk their drug development pipeline on accurate human models before and during clinical phases. In the future, the platform will be used to find and fine-tune treatments that will be reimbursed by the health insurers. With it we will ascertain that a… Show more DOPPL is implementing the worldwide first organoid automation and screening platform, that is validated to support clinical diagnostic services. The Company performs milestone-based co-development projects with pharmaceutical R&D to de-risk their drug development pipeline on accurate human models before and during clinical phases. In the future, the platform will be used to find and fine-tune treatments that will be reimbursed by the health insurers. With it we will ascertain that a treatment will work before giving it to the patient; reducing overall waste in health care costs. Show less



Ecole Polytechnique Fédérale de Lausanne (EPFL)

• Switzerland
• 1 - 100 Employee

• Project Manager and Entrepreneur

  • Mar 2015 - Jan 2016

  Lausanne und Umgebung, Schweiz



European Venture Programme

• Participant

  • Jul 2015 - Sep 2015

  Lausanne - Munich - Copenhagen - Eindhoven The European Venture Program offers five students or scientists from each of the four EuroTech Universities exclusive access to their tech entrepreneurship expertise and networking resources. Funded by the European Union Erasmus+ framework and co-funded by EuroTech. EuroTech Universities Alliance: - Swiss Federal Institute of Technology in Lausanne (EPFL) - Technical University of Munich (TUM) & UnternehmerTUM - Technical University of Denmark (DTU) - Eindhoven University of… Show more The European Venture Program offers five students or scientists from each of the four EuroTech Universities exclusive access to their tech entrepreneurship expertise and networking resources. Funded by the European Union Erasmus+ framework and co-funded by EuroTech. EuroTech Universities Alliance: - Swiss Federal Institute of Technology in Lausanne (EPFL) - Technical University of Munich (TUM) & UnternehmerTUM - Technical University of Denmark (DTU) - Eindhoven University of Technology (TU/e) Show less



Swiss Federal Institute of Technology Lausanne (EPFL)

• PhD student

  • Mar 2010 - Feb 2015

  Laboratory of Stem Cell Bioengineering Bioengineering approaches to emulate the stem cell niche.



The University of Tokyo

• Japan
• Research Services
• 700 & Above Employee

• Summer Research Program

  • Jul 2011 - Aug 2011

  Laboratory of Bioanalytical Chemistry Imaging of endogenous mRNAs in living cells using artificial nucleic acid antisense probes.



EPFL

• Switzerland

• Master project

  • May 2009 - Jan 2010

  Laboratory of Stem Cell Bioengineering Novel Microengineered Platform to Assess Stem Cell Fate in vitro (Identifying regulators of the MSC niche using a functionalised cellular hydrogel microarray)